Showing results (131-140 of 263) with videos related to
Sort By:
Pageof 27
Fundamental & Clinical Pharmacology|March 10, 2009
Are Zucker obese rats a useful model for cardiovascular complications in metabolic syndrome? Physical, biochemical and oxidative stress considerationsRégine Debin, Benjamin Lauzier, Pierre Sicard, et al.European Radiology|September 29, 2004
Visual estimation of the global myocardial extent of hyperenhancement on delayed contrast-enhanced MRIAlexandre Comte, Alain Lalande, Paul M Walker, et al.Journal of Clinical Medicine|January 12, 2021
The Multifaceted Interplay between Atrial Fibrillation and Myocardial Infarction: A ReviewAlban Belkouche, Hermann Yao, Alain Putot, et al.Investigative Radiology|May 18, 2007
Comparison of the extent of delayed-enhancement cardiac magnetic resonance imaging with and without phase-sensitive reconstruction at 3.0 TAlexandre Cochet, Alain Lalande, Paul M Walker, et al.Journal of Cardiovascular Pharmacology|March 20, 2009
Combining sirolimus-eluting stents and external irradiation in cholesterol-fed rabbits increased incomplete stent apposition and decreased re-endothelializationDavid Busseuil, Bertrand Collin, Gilles Rioufol, et al.European Heart Journal|March 20, 2018
Predicting the development of in-hospital cardiogenic shock in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: the ORBI risk scoreVincent Auffret, Yves Cottin, Guillaume Leurent, et al.The American Journal of Cardiology|January 1, 2017
Long-Term Clinical Outcomes According to Previous Manifestations of Atherosclerotic Disease (from the FAST-MI 2010 Registry)Etienne Puymirat, Nadia Aissaoui, Gilles Lemesle, et al.Archives of Cardiovascular Diseases|December 30, 2015
Cardiac rehabilitation and 5-year mortality after acute coronary syndromes: The 2005 French FAST-MI studyMarion Pouche, Jean-Bernard Ruidavets, Jean Ferrières, et al.British Journal of Clinical Pharmacology|November 14, 2018
Effectiveness and safety of 110 or 150 mg dabigatran vs. vitamin K antagonists in nonvalvular atrial fibrillationPatrick Blin, Caroline Dureau-Pournin, Yves Cottin, et al.Renal Failure|February 19, 2005
Influence of ischemia on heart-rate variability in chronic hemodialysis patientsIsaline Coquet, Christiane Mousson, Gerard Rifle, et al.Pageof 27